EUVIMEDEUVIMED entdecken
Crossref

Capillary electrokinetic chromatography for chiral separation of potential SARS‐CoV‐2 3CL protease inhibitors

Lucile Brier, Christophe Furman, Julie Charton, Benoit Deprez, Emmanuelle Lipka iD

ELECTROPHORESIS · 2024

DOI: 10.1002/elps.202300178 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ELECTROPHORESIS, 2024. Verfasst von Lucile Brier und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, Lille, France. Hauptthemen laut MEDLINE: SARS-CoV-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Institut Pasteur de Lille and the European Union-ERDF REACT-EU funds, Union response to Coronavirus pandemic, University of Lille and Région Hauts-de-France.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this work, a capillary electrophoresis method was developed as a quality control tool to determine the enantiomeric purity of a series of five chiral compounds evaluated as potential severe acute respiratory syndrome coronavirus 2 3CL protease inhibitors. The first cyclodextrin tested, that is, highly sulfated‐β‐cyclodextrin, at 6% (m/v) in a 25 mM phosphate buffer, using a capillary dynamically coated with polyethylene oxide, at an applied voltage of 15 kV and a temperature of 25°C, was found to successfully separate the five derivatives. The limits of detection and quantification were calculated together with the greenness score of the method in order to evaluate the method in terms of analytical and environmental performance. In addition, it is noteworthy that simultaneously high‐performance liquid chromatography separation of the enantiomers of the same compounds with two different columns, the amylose tris(3,5‐dimethylphenylcarbamate)‐coated and the cellulose tris(3,5‐dichlorophenylcarbamate)‐immobilized on silica stationary phases, was studied. Neither the former stationary phase nor the latter was able to separate all derivatives in a mobile phase consisting of n‐heptane/propan‐2‐ol 80/20 (v/v).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2StereoisomerismProtease InhibitorsCoronavirus 3C ProteasesChromatography, Micellar Electrokinetic CapillaryLimit of DetectionCOVID-19HumansChromatography, High Pressure Liquid

Stichwörter der Autor:innen

capillary electrophoresischiral separationgreen metricshigh performance liquid chromatography

Substanzen

Protease InhibitorsCoronavirus 3C Proteases

Autor:innen und Institutionen

  • University of Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, Lille, France.
  • University of Lille, Inserm, Institut Pasteur de Lille, U1167-Risk Factors and Molecular Determinants of Aging-related Diseases, Lille, France.

ORCID-Profile: Emmanuelle Lipka

Förderung

  • Institut Pasteur de Lille and the European Union-ERDF REACT-EU funds, Union response to Coronavirus pandemic
  • University of Lille and Région Hauts-de-France

Zitieren

APA

Brier, L., Furman, C., Charton, J., Deprez, B., & Lipka, E. (2024). Capillary electrokinetic chromatography for chiral separation of potential SARS‐CoV‐2 3CL protease inhibitors. ELECTROPHORESIS. https://doi.org/10.1002/elps.202300178

Vancouver

Brier L, Furman C, Charton J, Deprez B, Lipka E. Capillary electrokinetic chromatography for chiral separation of potential SARS‐CoV‐2 3CL protease inhibitors. ELECTROPHORESIS. 2024. doi:10.1002/elps.202300178

BibTeX
@article{Brier2024,
  author = {Brier, Lucile and Furman, Christophe and Charton, Julie and Deprez, Benoit and Lipka, Emmanuelle},
  title = {Capillary electrokinetic chromatography for chiral separation of potential SARS‐CoV‐2 3CL protease inhibitors},
  journal = {ELECTROPHORESIS},
  year = {2024},
  doi = {10.1002/elps.202300178}
}
Kostenlos starten →